Increased contribution of alpha 1- vs. beta-adrenoceptor-mediated inotropic response in rats with congestive heart failure

Acta Physiol Scand. 2003 Apr;177(4):449-58. doi: 10.1046/j.1365-201X.2003.01063.x.

Abstract

Aim: In failing myocardium the mechanical response to beta-adrenoceptor stimulation is attenuated. Alternative signalling systems might provide inotropic support when the beta-adrenoceptor system is dysfunctioning. Accordingly, the inotropic responses to alpha 1- and beta-adrenoceptor stimulation by the endogenous adrenoceptor agonist noradrenaline in non-failing and failing rat hearts were compared.

Methods: Chronic heart failure was induced in male Wistar rats by coronary artery ligation. Corresponding sham groups were prepared. After 6 weeks, papillary muscles from non-failing and failing hearts were isolated. Receptor binding studies were performed in the corresponding myocardium. The alpha 1-adrenoceptor-mediated inotropic response was not changed while the beta-adrenoceptor-mediated response was substantially reduced in failing compared with non-failing myocardium.

Results: No change in potency for the agonists was observed at the alpha 1-adrenoceptors, while an increased potency for the agonists at the beta-adrenoceptors was found during heart failure. The lusitropic response to beta-adrenoceptor stimulation was intact during heart failure. No over all change in affinity or number of either adrenoceptor type was observed in receptor binding studies. The alpha 1-adrenoceptor-mediated inotropic response became dominating compared with the beta-adrenoceptor-mediated one in failing rat myocardium in contrast to the dominating role of the latter in non-failing myocardium. The attenuation of the beta-adrenoceptor-mediated inotropic response in rat failing myocardium was not because of a reduced number of receptors.

Conclusion: Increasing contractility through stimulation of alpha 1-adrenoceptors in situ by the endogenous agonist may be an alternative way of inotropic support during heart failure and even more so during beta-adrenoceptor blockade.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology*
  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Cardiotonic Agents / pharmacology
  • Dose-Response Relationship, Drug
  • Heart Failure / physiopathology*
  • Isoproterenol / pharmacology
  • Male
  • Myocardial Contraction / drug effects*
  • Norepinephrine / pharmacology*
  • Phenylephrine / pharmacology
  • Rats
  • Rats, Wistar
  • Receptors, Adrenergic / physiology*
  • Receptors, Adrenergic, alpha-1 / physiology
  • Receptors, Adrenergic, beta / physiology
  • Vasoconstrictor Agents / pharmacology*

Substances

  • Adrenergic alpha-Agonists
  • Adrenergic beta-Agonists
  • Cardiotonic Agents
  • Receptors, Adrenergic
  • Receptors, Adrenergic, alpha-1
  • Receptors, Adrenergic, beta
  • Vasoconstrictor Agents
  • Phenylephrine
  • Isoproterenol
  • Norepinephrine